https://pipelinereview.com/transgene-receives-mhra-approval-for-a-clinical-trial-of-tg6002-a-next-generation-oncolytic-virus-administered-by-intrahepatic-artery-infusion-in-patients-with-colorectal-cancer-with-liver-metastases/
Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver Metastases